EDGAR Filing Documents for 0001072613-17-000004

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0001072613-17-000004

Filing Date

2017-01-06

Accepted

2017-01-06 15:31:08

Documents

Group Members

ANTHONY A. FLORENCE, JR.DAVID M. MOTTFOREST BASKETTM. JAMES BARRETTNEA 14 GP, LTDNEA PARTNERS 14, L.P.NEW ENTERPRISE ASSOCIATES 14, L.P.PATRICK J. KERINSPETER J. BARRISPETER W. SONSINIRAVI VISWANATHANSCOTT D. SANDELL

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13DA (#2)	strongbridge-sch13da2_18019.htm	SC 13D/A	425046
	Complete submission text file	0001072613-17-000004.txt		427051

Mailing Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093

Business Address 1954 GREENSPRING DRIVE SUITE 600 TIMONIUM MD 21093 410-842-4000

Growth Equity Opportunities Fund III, LLC (Filed by) CIK: 0001551055 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: SC 13D/A | Act: 34 | File No.: 005-89153 | Film No.: 17514155
SIC: 2834 Pharmaceutical Preparations